Cramer Rosenthal Mcglynn LLC trimmed its stake in Universal Health Services, Inc. (NYSE:UHS) by 48.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 181,630 shares of the health services provider’s stock after selling 168,242 shares during the period. Cramer Rosenthal Mcglynn LLC owned about 0.19% of Universal Health Services worth $20,588,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of UHS. Nationwide Fund Advisors grew its position in Universal Health Services by 6.7% in the 3rd quarter. Nationwide Fund Advisors now owns 168,650 shares of the health services provider’s stock worth $18,710,000 after purchasing an additional 10,593 shares during the last quarter. Crossmark Global Holdings Inc. bought a new position in shares of Universal Health Services during the 3rd quarter worth about $205,000. Victory Capital Management Inc. lifted its holdings in shares of Universal Health Services by 54.6% during the 3rd quarter. Victory Capital Management Inc. now owns 17,516 shares of the health services provider’s stock worth $1,943,000 after acquiring an additional 6,189 shares during the period. State of Wisconsin Investment Board lifted its holdings in shares of Universal Health Services by 6.0% during the 3rd quarter. State of Wisconsin Investment Board now owns 82,352 shares of the health services provider’s stock worth $9,136,000 after acquiring an additional 4,667 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in shares of Universal Health Services by 1.3% during the 3rd quarter. Prudential Financial Inc. now owns 211,047 shares of the health services provider’s stock worth $23,413,000 after acquiring an additional 2,680 shares during the period. Institutional investors own 87.57% of the company’s stock.
UHS has been the subject of a number of analyst reports. Royal Bank of Canada reaffirmed a “buy” rating and set a $134.00 price objective on shares of Universal Health Services in a report on Thursday, January 4th. Goldman Sachs Group initiated coverage on shares of Universal Health Services in a report on Wednesday, January 3rd. They set a “buy” rating and a $137.00 price objective for the company. Zacks Investment Research raised shares of Universal Health Services from a “hold” rating to a “buy” rating and set a $135.00 price objective for the company in a report on Wednesday, January 31st. Mizuho set a $137.00 price objective on shares of Universal Health Services and gave the stock a “buy” rating in a report on Wednesday, January 24th. Finally, Citigroup raised shares of Universal Health Services from a “neutral” rating to a “buy” rating in a report on Tuesday, December 12th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and twelve have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $133.40.
Universal Health Services, Inc. (UHS) opened at $123.89 on Wednesday. Universal Health Services, Inc. has a 1-year low of $95.26 and a 1-year high of $128.49. The stock has a market cap of $11,904.16, a PE ratio of 15.86, a P/E/G ratio of 1.21 and a beta of 0.92. The company has a current ratio of 0.97, a quick ratio of 0.90 and a debt-to-equity ratio of 0.69.
Universal Health Services (NYSE:UHS) last announced its quarterly earnings results on Wednesday, February 28th. The health services provider reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.16. Universal Health Services had a net margin of 7.23% and a return on equity of 15.06%. The firm had revenue of $2.64 billion during the quarter, compared to the consensus estimate of $2.64 billion. During the same period last year, the firm posted $1.80 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. equities analysts predict that Universal Health Services, Inc. will post 9.56 earnings per share for the current fiscal year.
Universal Health Services declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, November 15th that permits the company to buyback $400.00 million in shares. This buyback authorization permits the health services provider to purchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s leadership believes its stock is undervalued.
The company also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, March 1st will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Wednesday, February 28th. Universal Health Services’s dividend payout ratio is currently 5.12%.
TRADEMARK VIOLATION WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/03/14/universal-health-services-inc-uhs-shares-sold-by-cramer-rosenthal-mcglynn-llc.html.
Universal Health Services Profile
Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.
Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS).
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.